Lion's Mane Mushroom Benefits: What the Science Actually Shows (And What Japan Knew First)
Photo coming soon
The supplement industry discovered lion's mane around 2015. Japan has been eating it for roughly a thousand years. Both things are true, and understanding the gap between them clarifies what this mushroom actually does.
Walk into any health food store in the English-speaking world and you'll find lion's mane positioned as a discovery. The packaging says things like "ancient wisdom meets modern science" — which is technically accurate, but frames the history backwards.
The modern science is new. The ancient wisdom is Japanese. And the gap between what the research shows and what the supplement industry claims is significant enough that it's worth reading carefully.
This is what the evidence actually says.
What Lion's Mane Is (Without the Marketing)
Hericium erinaceus is a fungus. It grows on hardwood — living and dead — primarily in temperate forests across Asia, Europe, and North America. It fruits in a single large mass of white, cascading spines: the lion's mane the name refers to.
In Japan it is called yamabushitake (山伏茸) — "mountain monk mushroom." The name comes from the yamabushi, the mountain ascetics of Shugendo who practiced extreme austerities in the Japanese Alps and wore elaborate straw vestments. The mushroom's hanging white spines were said to resemble this costume. Yamabushi were present in Japanese mountain culture from the 8th century onward; the name suggests the mushroom has been noticed, named, and integrated into Japanese cultural memory for at least that long.
In Buddhist temple cuisine (shōjin ryōri), yamabushitake has appeared for centuries. Temple cooks valued it for its texture — the spines, when cooked, become tender and slightly chewy, with a mild, clean flavor that takes well to dashi and light seasoning. It was food before it was medicine, which is how most significant fungi entered Japan's medical tradition.
The Science: What Studies Have Actually Demonstrated
There are now hundreds of studies on Hericium erinaceus. Most of them are in vitro (cell culture) or animal studies. The number of well-designed human clinical trials remains small. This is not unusual for medicinal mushrooms — it is the normal state of research for most natural compounds — but it matters when evaluating claims.
The Compounds
The primary bioactive compounds identified in lion's mane belong to two families:
Hericenones — found in the mushroom's fruiting body (the part you eat). Extracted and named by Japanese researchers in the 1990s, primarily at Shizuoka University.
Erinacines — found in the mycelium (the fungal root network, not the visible mushroom). Also characterized largely through Japanese laboratory research.
Both compound families have been shown, in laboratory and animal studies, to stimulate the production of Nerve Growth Factor (NGF) — a protein that promotes the growth, maintenance, and survival of neurons. This is the mechanism behind most of lion's mane's cognitive claims.
NGF stimulation in a petri dish is not the same as cognitive improvement in a human. That gap is where most supplement marketing fails to make the distinction.
The Human Evidence: What We Have
The most-cited human clinical trial on lion's mane and cognition was published in 2009 in Phytotherapy Research by Mori and colleagues at Hokuto Corporation and Isogo Central and Neurosurgical Hospital in Japan (Mori, S. et al., 2009, Phytotherapy Research 23(3):367–372).
The study enrolled 30 adults diagnosed with mild cognitive impairment. Half received 1g of powdered H. erinaceus (Yamabushitake) three times daily — a total of 3g per day — for 16 weeks. The other half received placebo. Cognitive function was assessed at weeks 8, 12, and 16.
Results: the lion's mane group showed significantly higher scores on the cognitive function scale at weeks 8, 12, and 16 compared to placebo. No serious adverse events were reported.
The critical detail: four weeks after discontinuation, scores in the lion's mane group had declined significantly compared to the end of treatment.
This tells you something important about how this compound works — effects appear to be tied to ongoing consumption, not permanent neurological change. It also tells you that the effect, while statistically significant in this study, is not a cure. It is a modulation.
Since 2009, additional human studies have been conducted, primarily in Japan and China. A 2019 randomized controlled trial published in Biomedical Research (Saitsu et al., 2019) found improvements in cognitive scores in healthy adults over 50, using a lower dose over 12 weeks.
The cumulative picture from human trials: there is real evidence that lion's mane consumption is associated with measurable changes in cognitive function in adults, particularly those with mild impairment or age-related decline. The effects are real, reproducible, and dose-dependent.
What the evidence does not support: that lion's mane prevents dementia, reverses Alzheimer's disease, "regrows" neurons in clinically significant ways, or produces the effects shown in animal models at typical supplementation doses in healthy young adults.
The honest version of the science is interesting enough on its own. The inflated version is what you find on most supplement packaging.
Japan's Relationship with Yamabushitake: Different Epistemic Weight
When Japanese clinicians work with yamabushitake, they draw on something the Western supplement industry lacks: a long, unbroken tradition of observed use.
This is not mystical. It is empirical, just empirical in a different mode. When a compound has been consumed by human beings over centuries, when temple physicians and kampo practitioners have systematically observed which conditions it appears to help and which it doesn't, that observational database has evidential weight — not definitive weight, but meaningful weight.
The distinction matters for reading the research. When the 2009 Mori study found improvement in mild cognitive impairment, it was not discovering that lion's mane helps cognition. It was trying to understand why and how something that had been observed for generations appeared to work.
This is different from how Western research typically operates — discovering a compound, testing it, building a tradition of use from zero. Japan's fungi research begins with the tradition and works backward to mechanism. The approach changes what gets studied and how the results are interpreted.
That 1,400-year head start on observational data is one of the things AfterRain exists to make legible to the English-speaking world.
In the Kitchen: How Japan Actually Uses It
In Japanese supermarkets and specialty food stores, yamabushitake is available cultivated year-round, primarily from Nagano and Gifu prefectures where the main commercial growers operate. It is sold as food, not supplement. The price point reflects this: roughly equivalent to higher-end shiitake, not the premium pricing of Western supplement markets.
Japanese home cooks use yamabushitake primarily in three ways:
In hot pot (nabe): Added toward the end of cooking — the spines soften and absorb broth. The mild flavor works in both light dashi-based broths and richer miso or soy preparations. It is paired with chicken or with tofu in vegetarian preparations.
Sautéed with butter and soy: A simple preparation that highlights the mushroom's texture without competing with its flavor. The brief application of high heat concentrates the mild umami. Finish with a splash of soy and serve alongside rice.
In clear soup (suimono): Temple cuisine's preferred treatment. The mushroom's spines become delicate in light dashi — almost sea anemone-like in appearance. Seasonality matters here; temple cooks match the preparation to the occasion.
What Japanese cooks do not typically do: consume it as a supplement capsule as a primary strategy. The dried powder capsule is a Western invention, useful for standardizing dose in clinical trials but far removed from how this ingredient has been integrated into a diet for centuries.
The question of whether whole food consumption produces the same NGF-stimulating effects as standardized extract is a legitimate scientific question that has not been fully resolved.
The Supplement Industry Translation Problem
Here is what happens when a Japanese research compound becomes a global supplement product:
A Japanese laboratory study demonstrates that erinacines in H. erinaceus mycelium stimulate NGF production in cultured nerve cells. A supplement company in the United States reads the abstract, produces a mycelium-based product (mycelium is cheaper and faster to grow than fruiting bodies), and makes label claims about "supporting brain health" and "promoting nerve growth factor."
Three problems with this translation:
1. Mycelium vs. fruiting body: The compounds relevant to the most cited human trial (Mori 2009) were from the fruiting body. The hericenones that stimulate NGF in the fruiting body are structurally different from the erinacines in the mycelium. A mycelium-only product may have a different compound profile than what was tested clinically. Many budget supplements do not disclose which part of the fungus they contain.
2. Growing medium contamination: Commercial mycelium is typically grown on grain substrates (oats, brown rice, etc.). When the finished product is dried and powdered, it often contains significant amounts of grain — starch, not fungal compounds. Researchers like Paul Stamets have argued this can constitute 50–80% of the product weight. Third-party testing of commercial lion's mane products has found highly variable concentrations of active compounds.
3. Dose translation: The Mori 2009 trial used 3g/day of dried fruiting body powder. Many commercial capsule products contain 500mg–1g total per serving, often of mycelium-based powder of uncertain composition. Whether these doses produce measurable NGF effects in humans has not been established.
None of this means that lion's mane supplements don't work. Some do. The question is whether the specific product you're holding has been produced in a way that makes its claimed compounds bioavailable at a dose that research has shown to be meaningful.
Read the label carefully. Look for: fruiting body source, beta-glucan percentage, third-party testing. These are not guarantees, but they are better questions than "does lion's mane work."
What the Research Doesn't Tell You Yet
The honest gaps in current lion's mane research:
Long-term effects: The longest human trial in the literature runs 16 weeks. What happens with years of consumption is unknown.
Optimal dose: The effective doses in human trials range from 1–3g/day of dried fruiting body. The dose-response curve is not well characterized.
Neurodegeneration: Animal studies show promising results in Alzheimer's and Parkinson's models. Human trials for neurodegeneration are ongoing but not completed at the time of writing. Current evidence does not support claims that lion's mane treats or prevents Alzheimer's disease.
Healthy young adults: Most positive human trials were conducted in middle-aged to older adults with some degree of cognitive decline. Effects in healthy adults without cognitive impairment are less well documented.
Drug interactions: Lion's mane appears to have blood-thinning properties in some studies. People on anticoagulant medications should consult a physician before using it as a supplement.
If someone tells you that lion's mane is scientifically proven to prevent dementia or regenerate damaged nerves in humans, they are overstating what the research currently shows. The honest version — that it shows real promise in specific human populations, has a compelling mechanistic explanation, and has a long tradition of observed use behind it — is genuinely interesting and does not require exaggeration.
After the Rain
The thing about lion's mane in Japan is that it was never positioned as a miracle. It was yamabushitake — a mountain mushroom with an interesting flavor and a history in temple cooking, which happened to also be observed to be good for clarity of mind in older practitioners.
The monastery didn't need the randomized controlled trial to notice what was happening. The RCT was useful for understanding the mechanism. Both forms of knowledge have their place.
What gets lost in the supplement industry's version is the context: that this compound was embedded in a diet, in a practice, in a relationship with a specific landscape and tradition. Extracting it into a capsule and selling it as a standalone cognitive enhancer is not wrong, exactly, but it is a different thing than what yamabushitake has been for a thousand years in Japan.
After the rain, the mushrooms appear. They've always been there — in this case, in mountain monasteries and temple kitchens, quietly doing what mushrooms do.
AfterRain is named for the moment when something that was always there becomes visible.
A note on using lion's mane: This article is for informational purposes only and does not constitute medical advice. If you are considering lion's mane for cognitive support, consult a qualified healthcare provider, particularly if you take medications or have existing health conditions. Wild mushroom foraging requires expert identification — never consume foraged fungi based on written descriptions alone.
References
Tags: lion's mane benefits, lion's mane mushroom Japan, hericium erinaceus, yamabushitake, Japanese medicinal mushrooms, cognitive function, NGF, science vs hype, AfterRain
Topics